Shares of Bovie Medical Co. (NYSE:BVX) have been given an average broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation.

Brokers have set a 1-year consensus target price of $4.50 for the company and are forecasting that the company will post ($0.03) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Bovie Medical an industry rank of 176 out of 265 based on the ratings given to its competitors.

Several analysts recently weighed in on the stock. JMP Securities reiterated an “outperform” rating and issued a $5.00 price objective on shares of Bovie Medical in a research report on Wednesday, August 3rd. Zacks Investment Research upgraded shares of Bovie Medical from a “sell” rating to a “hold” rating in a research report on Tuesday, July 19th.

In other news, insider John J. Mccarthy III acquired 90,750 shares of the business’s stock in a transaction that occurred on Wednesday, August 17th. The shares were purchased at an average cost of $3.30 per share, for a total transaction of $299,475.00. Following the transaction, the insider now directly owns 115,750 shares in the company, valued at approximately $381,975. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

A hedge fund recently raised its stake in Bovie Medical stock. BlackRock Fund Advisors increased its position in Bovie Medical Co. (NYSE:BVX) by 27.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 72,051 shares of the medical device company’s stock after buying an additional 15,305 shares during the period. BlackRock Fund Advisors owned about 0.27% of Bovie Medical worth $118,000 at the end of the most recent quarter.

Shares of Bovie Medical (NYSE:BVX) opened at 4.97 on Thursday. The firm’s market capitalization is $134.44 million. The stock has a 50 day moving average of $4.50 and a 200 day moving average of $2.58. Bovie Medical has a 52-week low of $1.56 and a 52-week high of $5.69.

About Bovie Medical

Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.

5 Day Chart for NYSE:BVX

Get a free copy of the Zacks research report on Bovie Medical (BVX)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Bovie Medical Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bovie Medical Co. and related companies with's FREE daily email newsletter.